The levels of depression, anxiety and quality of life in patients with chronic idiopathic urticaria

被引:111
作者
Engin, B. [1 ]
Uguz, F. [2 ]
Yilmaz, E. [2 ]
Oezdemir, M.
Mevlitoglu, I. [1 ]
机构
[1] Selcuk Univ, Meram Med Fac, Dept Dermatol, TR-42080 Konya, Turkey
[2] Selcuk Univ, Meram Med Fac, Dept Psychiat, Konya, Turkey
关键词
anxiety; chronic idiopathic urticaria; depression; quality of life;
D O I
10.1111/j.1468-3083.2007.02324.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Chronic idiopathic urticaria (CIU) is associated with severely impaired quality of life (QoL). Objective To determine the levels of depression, anxiety and QoL in CIU patients. Patients and methods This study included 73 patients with CIU, and 34 healthy subjects matched for age and sex were used as controls. The levels of depression, anxiety and QoL were assessed with the Beck Depression Inventory (BDI), the Beck Anxiety Inventory (BAI) and the World Health Organization Quality of Life Assessment-Brief (WHOQOL-BREF), respectively. The reliability and validity of the Turkish versions of these instruments have been examined. Results When compared with healthy controls, patients with CIU had significantly higher BDI and BAI scores and significantly lower physical health and psychological health subscale scores of the WHOQOL-BREF. BDI, BAI and all domains of WHOQOL-BREF were unrelated to age, duration of illness, urticaria activity score (UAS) and visual analogue score (VAS). There was a negative significant correlation between all domains of WHOQOL-BREF and BDI and BAI. Conclusion Our data confirm that QoL is markedly reduced in CIU patients. Physical health and psychological health were found to be the areas QoL most affected in CIU patients. And also we have found that CIU patients frequently suffer from depression and anxiety. The severity of these parameters was found to be positively correlated with the extent of QoL decrease.
引用
收藏
页码:36 / 40
页数:5
相关论文
共 22 条
  • [11] Development of the World Health Organization WHOQOL-BREF quality of life assessment
    Harper, A
    Power, M
    [J]. PSYCHOLOGICAL MEDICINE, 1998, 28 (03) : 551 - 558
  • [12] Hashiro Makoto, 1994, Journal of Dermatological Science, V8, P129, DOI 10.1016/0923-1811(94)90007-8
  • [13] Hisli N., 1989, J PSYCHOL, V7, P2
  • [14] Quality of life in patients with multiple sclerosis: The impact of fatigue and depression
    Janardhan, V
    Bakshi, R
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 205 (01) : 51 - 58
  • [15] KAYA N, 2003, ANADOLU PSIKIYATR DE, V4, P220
  • [16] ODonnell BF, 1997, BRIT J DERMATOL, V136, P197
  • [17] Psychiatric morbidity in dermatological outpatients: an issue to be recognized
    Picardi, A
    Abeni, D
    Melchi, CF
    Puddu, P
    Pasquini, P
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2000, 143 (05) : 983 - 991
  • [18] Clinical significance of lifetime mood and panic-agoraphobic spectrum symptoms on quality of life of patients with rheumatoid arthritis
    Piccini, A
    Maser, JD
    Bazzichi, L
    Rucci, P
    Vivarelli, L
    Del Debbio, A
    Catena, M
    Bombardieri, S
    Dell'Osso, L
    [J]. COMPREHENSIVE PSYCHIATRY, 2006, 47 (03) : 201 - 208
  • [19] Poon E, 1999, BRIT J DERMATOL, V140, P667
  • [20] Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity
    Staubach, P
    Eckhardt-Henn, A
    Dechene, M
    Vonend, A
    Metz, M
    Magerl, M
    Breuer, P
    Maurer, M
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2006, 154 (02) : 294 - 298